Table 2 Summary of clinical characteristics of the MTH and control group patients

Age (years+/− SE)

55.56 ± 2.8

59.4 ± 2.9

0.358

Sex

11 males

11 males

0.779

VF/VT

16/16

13/15

0.131

Asystole

0/16

1/15

0.294

Hypertension

13/16

7/15

0.044

Diabetes

4/16

3/15

0.739

Prior myocardial infarction

2/16

3/16

0.570

Peripheral atherosclerosis

2/16

0/16

0.157

Heart failure

7/16

1/16

0.018

Coronary heart disease

4/16

2/15

0.411

CABG

1/16

0/15

0.325

AF

3/16

1/16

0.316

Renal failure

2/16

1/16

0.583

Prior stroke

1/16

0/15

0.325

Hyperthyroidism

0/16

1/15

0.294

Hypothyroidism

0/16

1/16

0.294

Smoking

9/16

6/16

0.366

COPD/asthma

1/16

1/16

0.962

Dyslipideamia

9/16

6/15

0.366

Final diagnosis

STEMI

7/16

9/15

0.366

NSTEMI

2/16

3/15

0.570

Cardiac shock

2/16

4/16

0.318

Heart failure

2/16

3/16

0.570

Myocarditis

2/16

1/16

0.583